| abstract |
IT REFERS TO A PHARMACEUTICAL COMPOSITION INCLUDING: a) HEMICALCICAL SALT OF ATORVASTATIN; b) AN ANTIHYPERTENSION AGENT MAY BE b1) A CALCIUM CHANNEL BLOCKER SUCH AS VERAPAMILO, DILTIAZEM, MIBEFRADIL, FELODIPINO, NIFEDIPINO, AMONG OTHERS; b2) AN ACE INHIBITOR SUCH AS BENAZEPRIL, CAPTOPRIL, ENALAPRIL, AMONG OTHERS; b3) AN AII ANTAGONIST SUCH AS LOSARTAN, IRBESARTAN OR VALSARTAN; b4) A DIURETIC SUCH AS AMILORIDE, BENDROFLUMETIAZIDE; b5) A �-ADRENERGIC RECEIVER BLOCKER SUCH AS CARVEDILOL; b6) AN O-ADRENERGIC RECEPTOR BLOCKER SUCH AS DOXAZOSINE, PRAZOSINE, TRIMAZOSINE. WITH THE CONDITION THAT THE ANTIHYPERTENSOR AGENT IS NOT AMLODIPINE. THE COMPOSITION HAS A SYNERGIC EFFECT REGARDING THE EFFECT OF THE FIRST AND SECOND COMPONENT SEPARATELY, MAY BE USEFUL AS ANTIANGINOUS, ANTIATEROSCLEROTIC, ANTIHYPERTENSIVE, HYPOLIPIDEMIC OR IN THE TREATMENT OF CARDIAC RISK |